These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 32416873)
21. Structure optimization of positive allosteric modulators of GABA Mugnaini C; Brizzi A; Mostallino R; Castelli MP; Corelli F Bioorg Med Chem Lett; 2020 Sep; 30(18):127443. PubMed ID: 32730942 [TBL] [Abstract][Full Text] [Related]
22. Potential of GABA Maccioni P; Colombo G CNS Drugs; 2019 Feb; 33(2):107-123. PubMed ID: 30604283 [TBL] [Abstract][Full Text] [Related]
23. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives. Urwyler S Pharmacol Rev; 2011 Mar; 63(1):59-126. PubMed ID: 21228259 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic potential of GABA(B) receptor ligands in drug addiction, anxiety, depression and other CNS disorders. Kumar K; Sharma S; Kumar P; Deshmukh R Pharmacol Biochem Behav; 2013 Sep; 110():174-84. PubMed ID: 23872369 [TBL] [Abstract][Full Text] [Related]
26. Structural Basis for Activation of the Heterodimeric GABA Kim Y; Jeong E; Jeong JH; Kim Y; Cho Y J Mol Biol; 2020 Nov; 432(22):5966-5984. PubMed ID: 33058878 [TBL] [Abstract][Full Text] [Related]
27. Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABAB receptor desensitization. Gjoni T; Urwyler S Neuropharmacology; 2008 Dec; 55(8):1293-9. PubMed ID: 18775443 [TBL] [Abstract][Full Text] [Related]
28. Trans-activation between 7TM domains: implication in heterodimeric GABAB receptor activation. Monnier C; Tu H; Bourrier E; Vol C; Lamarque L; Trinquet E; Pin JP; Rondard P EMBO J; 2011 Jan; 30(1):32-42. PubMed ID: 21063387 [TBL] [Abstract][Full Text] [Related]
29. Rearrangement of the transmembrane domain interfaces associated with the activation of a GPCR hetero-oligomer. Xue L; Sun Q; Zhao H; Rovira X; Gai S; He Q; Pin JP; Liu J; Rondard P Nat Commun; 2019 Jun; 10(1):2765. PubMed ID: 31235691 [TBL] [Abstract][Full Text] [Related]
30. Structural basis of the activation of a metabotropic GABA receptor. Shaye H; Ishchenko A; Lam JH; Han GW; Xue L; Rondard P; Pin JP; Katritch V; Gati C; Cherezov V Nature; 2020 Aug; 584(7820):298-303. PubMed ID: 32555460 [TBL] [Abstract][Full Text] [Related]
31. Asymmetric activation of dimeric GABA Liu L; Lin L; Shen C; Rondard P; Pin JP; Xu C; Liu J Am J Physiol Cell Physiol; 2023 Jul; 325(1):C79-C89. PubMed ID: 37184233 [TBL] [Abstract][Full Text] [Related]
32. [Molecular pharmacology of GABAA and GABAB receptors]. Hirouchi M; Kuriyama K Nihon Yakurigaku Zasshi; 1994 Sep; 104(3):199-206. PubMed ID: 7959412 [TBL] [Abstract][Full Text] [Related]
33. Activation mechanism of the heterodimeric GABA(B) receptor. Pin JP; Kniazeff J; Binet V; Liu J; Maurel D; Galvez T; Duthey B; Havlickova M; Blahos J; Prézeau L; Rondard P Biochem Pharmacol; 2004 Oct; 68(8):1565-72. PubMed ID: 15451400 [TBL] [Abstract][Full Text] [Related]
34. Allosteric ligands control the activation of a class C GPCR heterodimer by acting at the transmembrane interface. Liu L; Fan Z; Rovira X; Xue L; Roux S; Brabet I; Xin M; Pin JP; Rondard P; Liu J Elife; 2021 Dec; 10():. PubMed ID: 34866572 [TBL] [Abstract][Full Text] [Related]
35. Collision coupling in the GABA Kahanovitch U; Berlin S; Dascal N FEBS Lett; 2017 Sep; 591(18):2816-2825. PubMed ID: 28724189 [TBL] [Abstract][Full Text] [Related]